Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001641172-25-000512
Filing Date
2025-03-25
Accepted
2025-03-25 07:53:17
Documents
59
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 759979
2 ex31-1.htm EX-31.1 18979
3 ex31-2.htm EX-31.2 19618
4 ex32-1.htm EX-32.1 7357
5 form10-k_001.jpg GRAPHIC 2011
6 form10-k_002.jpg GRAPHIC 6031
  Complete submission text file 0001641172-25-000512.txt   4135668

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE gcan-20241231.xsd EX-101.SCH 32386
8 XBRL CALCULATION FILE gcan-20241231_cal.xml EX-101.CAL 32556
9 XBRL DEFINITION FILE gcan-20241231_def.xml EX-101.DEF 163176
10 XBRL LABEL FILE gcan-20241231_lab.xml EX-101.LAB 278738
11 XBRL PRESENTATION FILE gcan-20241231_pre.xml EX-101.PRE 248808
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 449603
Mailing Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208
Business Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208 (443) 738-4051
Greater Cannabis Company, Inc. (Filer) CIK: 0001695473 (see all company filings)

EIN.: 300842570 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-56027 | Film No.: 25765889
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)